GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (NYSE:IQV) » Definitions » Price-to-Free-Cash-Flow

IQV (IQVIA Holdings) Price-to-Free-Cash-Flow : 20.80 (As of Oct. 31, 2024)


View and export this data going back to 2013. Start your Free Trial

What is IQVIA Holdings Price-to-Free-Cash-Flow?

As of today (2024-10-31), IQVIA Holdings's share price is $205.82. IQVIA Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $9.90. Hence, IQVIA Holdings's Price-to-Free-Cash-Flow Ratio for today is 20.80.

The historical rank and industry rank for IQVIA Holdings's Price-to-Free-Cash-Flow or its related term are showing as below:

IQV' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 13.91   Med: 25.6   Max: 49.42
Current: 21.73

During the past 13 years, IQVIA Holdings's highest Price-to-Free-Cash-Flow Ratio was 49.42. The lowest was 13.91. And the median was 25.60.

IQV's Price-to-Free-Cash-Flow is ranked better than
54.12% of 85 companies
in the Medical Diagnostics & Research industry
Industry Median: 26.41 vs IQV: 21.73

IQVIA Holdings's Free Cash Flow per Share for the three months ended in Jun. 2024 was $2.42. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $9.90.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of IQVIA Holdings was 18.00% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 5.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 19.80% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 15.50% per year.

During the past 13 years, IQVIA Holdings's highest 3-Year average Free Cash Flow per Share Growth Rate was 58.60% per year. The lowest was -3.00% per year. And the median was 15.20% per year.


IQVIA Holdings Price-to-Free-Cash-Flow Historical Data

The historical data trend for IQVIA Holdings's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings Price-to-Free-Cash-Flow Chart

IQVIA Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.94 26.02 23.90 24.62 28.74

IQVIA Holdings Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.80 27.88 28.74 28.81 21.37

Competitive Comparison of IQVIA Holdings's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, IQVIA Holdings's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Price-to-Free-Cash-Flow falls into.



IQVIA Holdings Price-to-Free-Cash-Flow Calculation

IQVIA Holdings's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=205.82/9.896
=20.80

IQVIA Holdings's Share Price of today is $205.82.
IQVIA Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.90.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

IQVIA Holdings  (NYSE:IQV) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


IQVIA Holdings Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


IQVIA Holdings Business Description

Traded in Other Exchanges
Address
2400 Ellis Road, Durham, NC, USA, 27703
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Executives
Eric Sherbet officer: See Remarks 100 IMS DRIVE, PARSIPPANY NJ 07054-4235
Ari Bousbib director, officer: Chairman, CEO & Pres UNITED TECHNOLOGIES CORP, ONE FINANCIAL PLAZA, HARTFORD CT 06101
W Richard Staub officer: See Remarks
Kevin C Knightly officer: Pres Info & Tech Solutions 1499 POST ROAD, FAIRFIELD CT 06824
Panagos Constantinos officer: See Remarks 4280 EMPEROR BLVD, DURHAM NC 27703
Keriann Cherofsky officer: See Remarks 4280 EMPEROR BLVD, DURHAM NC 27703
Sheila A Stamps director C/O CIT GROUP, 1 CIT DRIVE, ATTN: GENERAL COUNSEL, LIVINGSTON NJ 07039
Morris Leslie Wims director 4280 EMPEROR BLVD, DURHAM NC 27703
John Connaughton director, 10 percent owner BAIN CAPITAL PARTNERS LLC, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Ronald E Bruehlman officer: See Remarks C/O IQVIA HOLDINGS, INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
Ronald A Rittenmeyer director 5400 LEGACY DRIVE, PLANO TX 75024
Tpg Group Holdings (sbs) Advisors, Inc. 10 percent owner C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Michael J Evanisko director BRAUN CONSULTING, 20 W KINZIE STREET SUITE 1600, CHICAGO IL 60610
Michael R Mcdonnell officer: Chief Financial Officer C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
John M. Leonard director C/O INTELLIA THERAPEUTICS INC, 40 ERIE STREET, SUITE 130, CAMBRIDGE MA 02139